VSee Health issues 40,000 shares to Clearthink in unregistered sale tied to $5 million equity line

VSee Health executed a Strata Purchase Agreement with Clearthink Capital Partners for up to $5 million of common stock sales.

The company will issue 40,000 common shares to Clearthink as a commitment fee in an unregistered transaction.

Stock sales, if any, can be initiated by the company over about 36 months once a resale registration statement is effective. The purchase price is set at 85% of the lowest daily close in the 10 trading days before each purchase date.

Clearthink ownership is capped at 9.99% of outstanding common stock under the agreement.